The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 07, 2020

Filed:

Jan. 11, 2017
Applicants:

Klox Technologies Limited, Dublin, IE;

Francesco Bellini, Calgary, CA;

Matteo Cerquetella, Matelica, IT;

Adolfo Maria Tambella, Matelica, IT;

Andrea Spaterna, Matelica, IT;

Nikolaos Loupis, Athens, GR;

David Ohayon, Dollard-des-Ormeaux, CA;

Remigio Piergallini, San Benedetto del Tronto, IT;

Inventors:

Francesco Bellini, Calgary, CA;

Matteo Cerquetella, Matelica, IT;

Adolfo Maria Tambella, Matelica, IT;

Andrea Spaterna, Matelica, IT;

Nikolaos Loupis, Athens, GR;

David Ohayon, Dollard-des-Ormeaux, CA;

Remigio Piergallini, San Benedetto del Tronto, IT;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/352 (2006.01); A61K 41/00 (2020.01); A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61K 31/17 (2006.01); A61K 33/40 (2006.01); A61P 27/16 (2006.01); A61P 31/02 (2006.01); A61K 47/38 (2006.01); A61K 31/4166 (2006.01); A61K 31/7008 (2006.01); A61K 31/715 (2006.01); A61K 45/06 (2006.01); A61K 47/32 (2006.01);
U.S. Cl.
CPC ...
A61K 31/352 (2013.01); A61K 9/0046 (2013.01); A61K 9/06 (2013.01); A61K 31/17 (2013.01); A61K 33/40 (2013.01); A61K 41/00 (2013.01); A61K 45/06 (2013.01); A61K 47/38 (2013.01); A61P 27/16 (2018.01); A61P 31/02 (2018.01); A61K 31/4166 (2013.01); A61K 31/7008 (2013.01); A61K 31/715 (2013.01); A61K 47/32 (2013.01); A61K 2300/00 (2013.01);
Abstract

The present disclosure describes methods and uses of biophotonic compositions which comprise at least one oxidant and at least one chromophore capable of activating the oxidant, in association with a pharmacologically acceptable carrier for the treatment of otitis externa.


Find Patent Forward Citations

Loading…